Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications.
D000328:Adult; D000368:Aged; D000639:Amitriptyline / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000401:mortality; D002319:Cardiovascular System / Q000187:drug effects*; D002648:Child; D003863:Depression / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D003891:Desipramine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D004316:Doxepin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D004562:Electrocardiography; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000401:mortality; D007099:Imipramine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D007700:Kinetics; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D010276:Parasympatholytics / Q000494:pharmacology; D011530:Protriptyline / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use
D000929:Antidepressive Agents, Tricyclic; D010276:Parasympatholytics; D004316:Doxepin; D000639:Amitriptyline; D011530:Protriptyline; D007099:Imipramine; D003891:Desipramine; D009638:Norepinephrine